Company ProfilePremium

WELLS PERFORMANCE MATERIALS LIMITED (formerly Wells Plastics Ltd.)

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
WELLS PERFORMANCE MATERIALS LIMITED - Company showcase

Year Founded & Workforce

1984

60 Employees

WELLS PERFORMANCE MATERIALS LIMITED logo

WELLS PERFORMANCE MATERIALS LIMITED Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

WELLS PERFORMANCE MATERIALS LIMITED Overview

FieldDetail
Entity profiledWells Performance Materials Limited (formerly Wells Plastics Limited)
Match rationaleExact legal-name match to "Wells Plastics Limited" for the period 7 Jun 1984 – 7 Jun 2024; same company number, still active [S10]
Current legal nameWELLS PERFORMANCE MATERIALS LIMITED [S10]
Former name(s)WELLS PLASTICS LIMITED (7 Jun 1984 – 7 Jun 2024) [S10]
Trading namesWells PM; Wells Performance Materials; brands BACTIglas™, Reverte™, Compol™ [S59]
Company number01822612 (England & Wales) [S10]
Legal formPrivate limited company [S10]
Listing statusNot listed. Privately held. The input list's "Public company" classification is incorrect.
Founded / incorporatedIncorporated 7 June 1984 [S10]; founded in 1984 by Danny Wells [S59]
JurisdictionEngland & Wales (Companies Act)
Registered office / HQEmerald Way, Stone Business Park, Stone, Staffordshire, ST15 0SR, United Kingdom [S10][S59]
SIC code22290 – Manufacture of other plastic products [S10]
Stock exchange / tickerNone (not listed)
ISIN / CUSIPNot applicable (no listed securities)
Fiscal year end30 June [S10][S19]
Latest filed accountsFull accounts for the year to 30 June 2025, filed 14 April 2026 (35 pages) [S19]
Next accounts dueYear to 30 June 2026, due by 31 March 2027 [S39]
Latest confirmation statementMade 16 September 2026 "with updates" [S19]
Immediate parent / PSCWellstopco Limited (company no. 14248252), holding ≥75% of shares and voting rights, notified 26 March 2026 [S61]
Prior PSCR&E Holdings Ltd (company no. 03356524), from 22 Sep 2022 to 26 Mar 2026 [S61]
Ultimate controlling partyNot publicly disclosed in sources retrieved. Per the 2022 MBO announcements, it is management-owned (Carl Birch, Stuart Law and Dr Gary Ogden) [S52]
Employees (latest)"Nearly 60" (WMG case study, 29 June 2026) [S24]; 60 (PitchBook) [S62]; 57 (Datanyze) [S63]
AuditorNot publicly disclosed in sources retrieved. It is named in the filed full accounts.
Market capitalisationNot applicable (private). Equity value not publicly disclosed.
Websitehttps://wellspm.com (legacy: wellsplastics.com) [S59][S57]
Brand websitesbactiglas.com; revertebio.com (launched March 2025); reverteplastics.com (legacy) [S59][S60]
Stated capacityIn excess of 12,000 tonnes per annum (current) [S4]. It was over 10,000 t/a at the time of the October 2022 MBO [S52][S53].
Operations24/7 manufacturing across four sites in Stone, covering innovation, manufacturing and warehousing [S4]
Metric2013202220242026
Employees (headcount, approx.)40——60

Sources: "over 40" at the Stone site (British Plastics, c. Jan 2013) [S3]; "nearly 60" (WMG, June 2026) [S24]. One aggregator (a-leads) shows only 25 LinkedIn-linked employees with −7.4% yearly growth [S7]. This reflects LinkedIn coverage rather than true headcount and conflicts with the 57–60 range from other sources.

Wells Performance Materials is a family-founded, now management-owned specialty chemicals manufacturer in Stone, Staffordshire. It describes itself as the largest independent specialist additive masterbatch and compound producer in the United Kingdom. Wells does not make colour masterbatch. Instead, it formulates and compounds functional additives into easy-to-dose carrier pellets for plastics processors and brand owners. These additives include antimicrobials, oxo-biodegradation promoters, slip and antiblock agents, antistatics, UV stabilisers, antioxidants, flame retardants, blowing agents, fragrances, processing aids and purge compounds. Its two proprietary brands, BACTIglas™ (antimicrobial) and Reverte™ (biodegradable additive for polyolefins), give it intellectual property and regulatory know-how unusual for a firm of roughly 60 people. Around these brands sits a toll-compounding and bespoke-formulation business with over 12,000 t/a of capacity. Wells sells into film, packaging, agriculture, automotive, medical and food-contact markets in the UK, Europe and export territories. Its competitive edge rests on handling difficult raw materials, rapid development and regulatory expertise. Its principal exposure is to plastics-policy risk, especially around oxo-degradable additives and PFAS.


What the company does

Wells is an additive masterbatcher and compounder. A masterbatch is a concentrated blend of one or more additives dispersed in a polymer carrier, supplied as pellets. A processor (a film blower, injection moulder or fibre spinner) adds it at a low let-down ratio to base resin to give the finished article a functional property. Many functional additives are powders, liquids, waxes or high-viscosity fluids that are difficult, hazardous or inconsistent to dose directly. Wells' core value proposition is converting these into homogeneous, free-flowing pellets so the customer gets the function without the handling problem [S4][S59].

The company's own description, paraphrased from its website and trade-directory listing, positions it as follows [S4][S59]:

  • the UK's largest independent specialist additive masterbatch and compound manufacturer, with over 12,000 t/a of capacity;

  • working across a wide range of polymer bases, including polyolefins, biopolymers, bio-based and compostable polymers, EVAs, EMAs and nylons;

  • offering pellet formats from conventional strand pellets through die-face-cut to micro-pellets;

  • providing the full chain from product development, pilot trials and material selection to full-scale production, plus a catalogue of off-the-shelf grades;

  • developing, manufacturing and owning the BACTIglas™ and Reverte™ brands.

The Sales & Marketing Director has emphasised that, although Wells performs R&D both internally and for clients, it sees itself as a manufacturer whose goal is commercially viable solutions [S23].

Business model and revenue model

Revenue streamDescriptionDisclosure status
Proprietary branded additivesBACTIglas™ antimicrobial masterbatches, compounds and powders; Reverte™ biodegradable masterbatchesRevenue split not publicly disclosed
Catalogue functional masterbatchesSlip, antiblock, antistatic, UV, antioxidant, flame retardant, blowing agents, fragrance, processing aids, purge compounds—
Bespoke formulationsCustomer-specific additive packages developed and manufactured by Wells—
Contract / toll compoundingManufacturing to customers' own formulations on Wells' twin-screw lines—
Technical servicesDevelopment, pilot trials, testing (expanded with a new Instron testing system in 2026) [S24]Not disclosed; likely embedded in product pricing
Biopolymer compoundsCompol™ bio-based and biopolymer materials—

Independent characterisation: Revenue is overwhelmingly product revenue (tonnes sold × price per kg), with no material subscription or licensing component in public sources. Branded ranges are sold via direct sales and, since 2012, an expanded international distributor network [S59]. Pricing is likely cost-plus on raw-material indices with a premium for proprietary chemistries, although no pricing disclosures exist.

Value-chain position

StagePlayersWells' role
UpstreamPolymer producers (resins); additive chemical producers (slip amides, antistatic GMS, HALS UV stabilisers, silver/zinc antimicrobials, transition-metal pro-oxidants, etc.)Buyer of carrier resins and raw additives
Mid-streamMasterbatch and compound producersWells' core position
Downstream conversionFilm blowers, sheet extruders, injection moulders, fibre spinnersPrimary direct customers
End-useRetailers, brand owners, packaging buyers, medical-device OEMs, agricultureOften specify Wells' brands (e.g. antimicrobial refuse sacks, biodegradable carrier bags)

Wells sits in the mid-stream of the plastics value chain:

Customer types and end-markets

End-marketRepresentative applicationsKey brand / product
Flexible packaging & filmSlip/antiblock for PE film, antistatic film, stretch and shrink filmSlips, Antiblocks, Antistatics, Processing Aids
Retail/carrier bags & refuse sacksBiodegradable bags, antibacterial refuse sacksReverte™, BACTIglas™
AgricultureUV-stabilised films, biodegradable mulch-type applicationsUV masterbatches, Reverte™
Medical devicesAntimicrobial polymer componentsBACTIglas™
Food contact / food packagingAntimicrobial packaging, slip/antiblockBACTIglas™, Slips
AutomotiveFlame retardants, stabilisers, bespoke compoundsFlame Retardants, Antioxidants
Mass transportAntimicrobial touch surfacesBACTIglas™
Point-of-sale / consumer goodsScented articles, odour masking in recyclateFragrances
Foams / lightweightingEndothermic and exothermic chemical foamingBlowing agents
RecyclingOdour elimination and stabilisation of recyclateFragrances, Antioxidants

The company lists end customers in automotive, medical, food, and agriculture [S59], plus food packaging [S24]. Historic investor descriptions add consumer, construction and agriculture [S8][S57]. BACTIglas™ is positioned for medical devices, mass transport and food packaging [S59], with documented use in refuse sacks [S63]. Reverte™ historically had particular success in plastic carrier bags [S51]. Wells also states that it serves customers ranging from polymer producers to medical-device makers [S59].

Strategy

Stated strategic themes (paraphrased from company communications)

  1. Repositioning from "plastics" to "performance materials." The June 2024 rebrand was explicitly framed as reflecting a broader portfolio of additive masterbatches and bespoke compounds, a stronger ESG commitment, and clearer communication with customers and stakeholders [S23][S31].

  2. Sustainability-enabling additives. Wells frames its role as supporting UK and EU plastics strategies by making standard polymers more recyclable and reusable in demanding applications. Examples include desiccants for recyclate, odour control, antioxidants for re-stabilisation, and PFAS-free processing aids [S1][S60].

  3. Technical partnership and commercial conversion. The company stresses commercial manufacture over pure R&D, offering a full pathway from development through pilot to scale [S23][S59].

  4. Growth in the UK and Europe and on the global stage. The 2026 testing investment was explicitly tied to growing market share in the UK and Europe and competing globally [S24].

  5. Management ownership and incentivisation. The 2022 MBO was positioned as aligning the executive team with long-term success [S52].

Initiative register (last 24 months, Oct 2024 – Oct 2026)

DateInitiativeCategoryDetailSource
Jun 2024 (ongoing)Rebrand to Wells Performance MaterialsCorporate / brandNew name, logo and 40th-anniversary event[S23][S19]
Feb 2025Commercial team hire (Dean Fosbury)OrganisationAppointment announced[S60]
Mar 2025Reverte™ digital relaunch (revertebio.com)Brand / marketingNew brand site focused on making ordinary plastics biodegradable[S60]
Apr–Jun 2025European trade-show programmeCommercial expansionPlastteknik Nordic (May 2025); AMI Masterbatch Málaga (June 2025)[S60]
Jun 2025Pellet-loss prevention / Operation Clean Sweep leadershipESGProfiled by the BPF as setting an industry standard in pellet-loss prevention[S60]
Oct 2025EU PFAS regulatory updateRegulatory / productCustomer guidance on EU PFAS restrictions[S60]
Nov 2025Microplastics regulatory statementRegulatory / product defenceIssued by the Regulatory Affairs Manager[S60]
Nov 2025Plastics Live IrelandCommercialMarket development in Ireland[S60]
2025–26Made Smarter West Midlands / WMG digital-investment projectCapex / capabilityNew Instron testing system, grant of £16k+[S24]
Mar 2026AMI Stretch & Shrink Film, MálagaCommercialFilm-additive focus[S60]
Apr 2026PFAS-free process aids under the PPWRProduct / regulatoryClarification of compliance of PFAS-free processing aids with the EU Packaging & Packaging Waste Regulation[S60]
Jun 2026Interplas 2026CommercialExhibition reported as successful[S60]
Jun 2026Reverte™ microplastic reportProduct defence / scienceTest results presented as showing no microplastics from Reverte™ technology[S60]
Sep 2026AMI Compounding & Recycling Expo (23–24 Sep 2026)CommercialCompounding and recycling market positioning[S60]
Sep 2026Refinancing (new charge, MBO charges satisfied)Capital structureSee Sections 6 and 21[S19]

Medium-term financial targets / guidance

None publicly disclosed. As a private company, Wells issues no guidance. The only quantified operational ambition in the public domain is the capacity path (over 10,000 t/a in 2022, over 12,000 t/a currently) [S52][S4].

Products & Services

Launch years are given where disclosed. Pricing is not publicly disclosed for any product line. All descriptions are paraphrased from company materials [S59][S1][S4][S9] unless otherwise cited.

Proprietary brands

Product / brandDescription & capabilitiesTarget customersLaunch / versionNotes
BACTIglas™Antimicrobial masterbatches, compounds and powders that give polymer articles resistance to microbial growthMedical-device makers, mass-transport interiors, food-packaging converters, refuse-sack producersMarket entry 1999Dedicated site bactiglas.com. Datanyze profile notes more than 20 years in antimicrobial grades for health and care applications, including medical devices, food packaging and refuse sacks [S63].
Reverte™Additive masterbatches that give conventional polyolefins (PE, PP) a biodegradable property, historically described as oxo-biodegradableFilm and bag producers, retailers; export markets (Middle East, Africa, South America were the 2011 targets)Technology 2003; brand 2005; new website Mar 2025Main driver of the 2011 MBO thesis [S54]. Volumes up about 20% year-on-year around 2012–13 [S3]. A microplastics test report was published June 2026 [S60].
Compol™Biopolymer and bio-based materials for extrusion and injection mouldingConverters seeking bio-based or compostable materials—Leverages Wells' biopolymer carrier experience [S4]

Functional additive masterbatches

Product lineDescriptionProcess / applicationsNotes
Slip masterbatchesLower and control the coefficient of friction in film and moulded partsBlown/cast film, injection mouldingCatalogue and bespoke grades
Antiblock masterbatchesPrevent film layers from sticking (blocking)Film and sheetWide range
Antistatic masterbatchesDissipate static chargeFilm, sheet, injection mouldingWide range
UV stabiliser masterbatchesImprove resistance to UV degradationAgricultural film, outdoor articles; historic founding expertise in 1984 [S59]Core heritage line
Antioxidant masterbatchesStabilise polymer during processing, in use and during recyclingBroad range of processesRelevant to recycled-content growth
Flame retardant masterbatches & compoundsBespoke flame-retardant solutionsAutomotive, construction, electricalBespoke emphasis
Blowing agentsEndothermic and exothermic chemical foaming agents as masterbatch or powderExtrusion and injection moulding; weight reductionWells supplies both chemistries [S1]
Desiccant masterbatchHigh-performance moisture scavenger that cuts filter blocking and film tears caused by large particlesRecycled-feedstock film extrusionPositioned against lower-cost desiccants [S1]
Fragrance masterbatchesAdd scent to point-of-sale items or mask unwanted odours in recycled feedstockConsumer goods, recyclateOdour-masking supports recycling
Processing aidsImprove extrusion quality and appearance while reducing waste and energy useFilm extrusionPFAS-free grades; regulatory clarification issued Apr 2026 [S60]
Purging & cleaning compoundsHelp purging, cleaning and shut-down of extrusion equipmentAll extrudersConsumable product

Services

ServiceDescriptionCapability / evidence
Bespoke formulationCustom additive packages from concept to productionProject management, rapid sampling, after-sales follow-up [S59]
Contract (toll) compoundingProduction to client formulationsTwin-screw lines (two added in 2018) [S2]; 24/7 operation [S4]
Pilot trials & material selectionLab-to-pilot scale-upInnovation Centre (opened Dec 2022) [S59][S70]
Testing & QCMechanical and physical property testingNew Instron system, supported by a Made Smarter grant of £16k+ (2026) [S24]
Pellet formatsStrand pellet, die-face-cut, micro-pelletMicro-pellets relevant for rotomoulding and fine dispersion [S4]
Regulatory advisoryGuidance to customers, NGOs and national bodies on correct product selection and useRegulatory Affairs Manager Julie Simmons MRSC; statements on microplastics (Nov 2025) and PFAS (Oct 2025, Apr 2026) [S60]

Financial Narrative

Data availability statement

Wells files full accounts (31–37 pages) for FY2022 through FY2025 [S19]. Their length and "full" designation suggest the company prepares audited statements with a strategic report, which typically signals a medium-sized company or one that elects full disclosure.

Verified historical datapoints

FY2010 (year to 30 Jun 2010): sales £8.7m, PBT £1.4m [S8]. The ~£10m "reported turnover" is from British Plastics c. Jan 2013 and is approximate; the exact fiscal year is not stated [S3]. A US-centric aggregator estimate of "$6.2M revenue" (Datanyze) attaches a US address in error and is disregarded as unreliable [S63].

Income statement (5-year)

EPS and DPS are not meaningful for a private company with a single corporate shareholder. Revenue CAGR cannot be computed.

Commentary: what can be inferred without the accounts

Although the numbers are unavailable, several qualitative financial signals can be drawn from registry and press evidence.

Scale. The business generated £8.7m of sales in FY2010 [S8] and about £10m around 2013 [S3]. Since then, capacity has risen from roughly the 2013 level through a 25% output increase (2013) and a 40% capacity uplift (2018) to over 12,000 t/a [S3][S2][S4]. Management also states the company has doubled in size over the past decade [S23]. The polymer and additive inflation of 2021–2022 would have added price-driven turnover growth. Taken together, current turnover is plausibly well above the 2013 level. No figure is asserted here; the filed accounts should be consulted.

Profitability heritage. A 16% pre-tax margin in FY2010 [S8] is high for a compounder. It reflects the proprietary-brand mix (Reverte™ was then the growth engine) and supported a private-equity investment thesis. Whether that margin has held up against stricter regulation of oxo-degradable plastics in the EU is a key unknown.

Leverage and financing events. The registry shows a clear capital-structure history:

  • the 2011 MBO used NatWest senior debt [S51];

  • the October 2022 secondary MBO was funded by a Virgin Money package, with four charges (14–17) created on 21 October 2022 [S19][S53];

  • debt was progressively repaid or refinanced, with charge 17 satisfied in October 2024 and legacy charges 12 and 13 in May 2025 [S19];

  • in September 2026 a new charge (18) was registered, and charges 15 and 16 from the MBO were satisfied [S19].

The satisfaction of MBO-era security within four years points to deleveraging and/or a refinancing onto new terms in September 2026. Charge 18 is recorded as satisfied on 14 September 2026, eleven days after it was created [S19]. This is unusual. It could reflect a short bridge facility, a filing correction, or a replaced instrument, and should be checked against the charge documents.

Filing timeliness. The FY2022, FY2023 and FY2025 accounts were filed on 8 April 2023, 10 April 2024 and 14 April 2026 respectively [S19]. Each date falls slightly after the standard nine-month deadline (31 March) for a 30 June year end. Whether filing extensions were granted is not visible in the public record. FY2024 accounts were filed on time (17 March 2025).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Business Lines

Business line (analytical)ContentsProprietary?

A. Proprietary Brands

BACTIglas™ (antimicrobial); Reverte™ (biodegradable additive for polyolefins)

Yes – own brands and know-how

B. Functional Additive Masterbatches

Slip, antiblock, antistatic, UV, antioxidant, flame retardant, blowing agents, fragrances, processing aids

Catalogue and bespoke

C. Specialty Compounds & Biopolymers

Compol™ biopolymer/bio-based compounds; purge and cleaning compounds

Partly proprietary

D. Contract Services

Toll compounding, bespoke development, pilot trials

Service-based

Group Entities

EntityCompany no.RoleNotes

Wellstopco Limited

14,248,252

Immediate parent; ≥75% shares and votes since 26 Mar 2026

Company number sequence suggests incorporation around mid-2022, consistent with use as the Oct 2022 MBO vehicle. This is an inference, not confirmed. [S61]

R&E Holdings Ltd

03,356,524

PSC 22 Sep 2022 – 26 Mar 2026; also held the right to appoint or remove directors

Company number sequence suggests incorporation around 1997, coinciding with the 1997 change of management. Inference only. [S61]

Wells Performance Materials Limited

01,822,612

Trading/operating company

All manufacturing, sales and IP activity appears to sit here

Income Statement and Margin Analysis (%)

Metric (GBP Mn)FY2010FY2013

Revenue

8.710

Pre-tax profit

1.4—

Pre-tax margin (%)

16.1—

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Region Overview

RegionEvidenceAssessment

United Kingdom

Described as a very strong UK base; largest independent UK specialist additive masterbatcher [S59]

Core market; probably the largest single country

Continental Europe

Strong presence in Europe [S59]. Exhibited at AMI Masterbatch (Málaga, June 2025), Plastteknik Nordic (Malmö, May 2025), AMI Stretch & Shrink Film (Málaga, 2026). The WMG project aimed to grow share in the UK and Europe [S24][S60].

Active growth target, especially the Nordics and Iberia

Ireland

Exhibited at Plastics Live Ireland, November 2025 [S60]

Developing market

Middle East, Africa, South America

Explicit Reverte™ export targets at the 2011 MBO [S54]

Historically important for Reverte™. Current weight unknown.

Americas & Far East

Customer base said to stretch from the Americas to the Far East [S59]

Present via distributors

Southeast Asia

An aggregator records one employee in Southeast Asia [S7]

Possible sales representative. Unconfirmed.

Capital Markets

ItemStatus

Share price performance (1/3/5-year)

Not applicable (not listed)

Analyst consensus

None (no coverage)

Dividend history and policy

Not publicly disclosed (dividends to the parent would appear in the accounts)

Credit ratings (Moody's / S&P / Fitch)

Not rated

Debt providers

NatWest (to 2022) [S3][S51]; Virgin Money UK (from Oct 2022) [S53]; lender of the Sep 2026 charge not identified

Balance Sheet

Funding event (GBP Mn)FY2011FY2013

Private equity / shareholder equity injected

3.81.5

Peer Comparison

PeerMarket capRevenue (ttm)Implied EV/Sales

Symphony Environmental (AIM: SYM)

About £19.5m (7 Jul 2026)

£5.73m (FY2025)

About 3.4x market cap/sales (before net debt or cash adjustment)

Analyst Conclusions

Management guidance

None published. Qualitative direction from 2025–26 communications [S24][S60]:

  • grow share in the UK and Europe;

  • invest in testing and R&D capability;

  • defend and develop Reverte™ with scientific evidence;

  • lead on PFAS-free and recyclate-enabling additives.

Consensus expectations

None (no analyst coverage).

Bull case

  1. Regulation-led product pull. EU PFAS restrictions and recycled-content mandates create demand for exactly the niche additives Wells makes (PFAS-free processing aids, desiccants, odour control, re-stabilisers) [S1][S60]. Large competitors may be slower to serve small-volume, high-specification needs.

  2. Capacity and capability already built. Successive expansions (2013, 2018, 2022 Innovation Centre, 2026 Instron) mean growth can come from volume on existing assets [S3][S2][S59][S24]. Satisfying most MBO-era charges by September 2026 suggests improving balance-sheet headroom [S19].

  3. Biodegradable-additive cycle turning. The closest peer swung to H1 2026 profit with revenue up 23% [S74], and some non-EU jurisdictions are accepting oxo-type technologies [S71]. A recovering Reverte™ market would give Wells high-margin operating leverage, as in FY2010's 16% PBT margin [S8].

Bear case

  1. Reverte™ regulatory risk. EU restrictions and microplastics scrutiny could permanently shrink the addressable market for the technology that underpinned the 2011 investment thesis [S54][S60].

  2. Scale and concentration. With about 60 staff and one town of operations [S24][S4], Wells is exposed to single-site disruption, key-person risk and procurement disadvantage against Avient, Ampacet and LyondellBasell.

  3. Opacity and governance. A two-person statutory board, apparent recurring late filings and an unusual eleven-day charge in September 2026 [S19][S20] raise questions a lender or acquirer would need to resolve through diligence.

Key catalysts and monitorables (next 12 months)

MonitorableTimingWhy it matters
FY2026 full accounts (YE 30 Jun 2026)Due by 31 Mar 2027First audited view after the rebrand and refinancing; check turnover trend, margin, net debt and filing timeliness
Charges register clarification (charges 14 and 18)NowConfirms current secured-debt position and lender
Shareholding detail in the 16 Sep 2026 confirmation statementNowIdentifies the beneficial owners behind Wellstopco
Directors' ECCTA identity verificationBy 30 Oct 2026Compliance hygiene
EU microplastics, PFAS and Green Claims developmentsRollingDirect impact on Reverte™ and processing aids
EcoVadis medal renewalAnnualCustomer qualification
European trade-show conversion (Nordics, Iberia, Ireland)2026–27Validates the European growth strategy
Symphony Environmental interim and FY resultsSep 2026 / mid-2027Read-across on biodegradable-additive demand

Analyst verdict

Wells Performance Materials, still widely known as Wells Plastics, is not the public company the input list suggests. It is a 42-year-old, management-owned specialist manufacturer in Staffordshire. It has carved out a defensible niche as the UK's largest independent producer of functional additive masterbatches and compounds. The core of the investment case is technical depth combined with nimbleness. Wells turns awkward chemistries into easy-to-dose pellets, holds two long-lived proprietary brands in BACTIglas™ and Reverte™, and has invested steadily in capacity and innovation infrastructure. That infrastructure now supports over 12,000 tonnes a year. Its ESG and regulatory credentials are notably mature for a firm of roughly 60 people, and they are now a commercial necessity for supplying multinational converters.

The central strategic tension is product mix. Reverte™, an oxo-type biodegradable additive, drove the high-margin growth that attracted private equity in 2011. It now sits in the crosshairs of EU single-use-plastics and microplastics policy. Management's response is sensible: defend the technology with published test data, while redirecting growth toward regulation-favoured niches such as PFAS-free processing aids, recyclate enablers and biopolymers. Whether that pivot has protected margins cannot be judged from public sources.

On balance, the evidence points to a stable, deleveraging, owner-managed specialist rather than a distressed or high-growth story. MBO-era security has largely been released, capex continues, the team is expanding, and newsflow is steady and benign. The principal diligence flags are governance thinness, apparent late filings and the ambiguous September 2026 charge. Verdict: a credible niche operator with moderate regulatory risk. It is suitable as a supplier or partner, and its acquirability and financial health should be confirmed from the filed accounts before any credit or investment decision.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedYear of birth (month)Background

Carl Birch

Director; Sales & Marketing Director

1 Jul 2005

Feb 1971

Former sales manager (2011). Co-led the 2022 secondary MBO. Public face of the company at trade shows.

Stuart Bryan Law

Director (since 17 Feb 2011); Company Secretary (since 17 Apr 2009); Finance & Operations Director

17 Feb 2011

Apr 1968

Co-led the 2022 secondary MBO

Executive Leadership Team

NameTitleNotes

Carl Birch

Sales & Marketing Director

Shareholder

Stuart Law

Finance & Operations Director

Shareholder

Dr Gary Ogden

Technical Manager / head of Technical Team

Became a shareholder at the 2022 MBO; leads collaborative R&D

Stephen Bell

Executive Management Team member

Title not disclosed

Michael Spight

Supply Chain Manager

Led the 2026 Made Smarter / WMG testing investment

Martin Cooper

Executive Management Team member

Title not disclosed

Julie Simmons MRSC

Regulatory Affairs Manager

Issued the 2025 microplastics regulatory statement

Dean Fosbury

Joined February 2025

Role not confirmed in sources retrieved

Ted Goold

Chairman (per aggregator only)

May chair at holding-company level or in an advisory capacity.

Board of Directors — Daniel A. C. (Danny) Wells

NameRoleTenure

Daniel A. C. (Danny) Wells

Founder, director

1984 – 12 Jun 1997

Gladys Y. Wells

Director and Secretary

to 12 Jun 1997

Peter Davis

Director

to 12 Jun 1997

David A. Nelson

Director / Managing Director

12 Jun 1997 – 17 Feb 2012

Stuart P. D. Teare

Director and Secretary

12 Jun 1997 – 30 Apr 2006

Paul J. Morris

Director

1 Mar 1999 – 7 Apr 2000

Andrew C. Barclay

Technical Director

1 Jul 2005 – 18 Jun 2012

Ryan M. Ashley

Secretary

1 May 2006 – 17 Apr 2009

Paul Richardson

Executive Chairman (2011 MBO; ex-KIK Corp, Cott Corp)

from Feb 2011

Andy Gregory

Non-executive director (KCP)

from Feb 2011

Dr Neil Partlett

Chief Executive

quoted c. 2013

Governance Overview

DimensionAssessment

Independence

No independent directors on the statutory register

Committees

No audit, remuneration or nomination committees disclosed (not required for a private company)

Chair/CEO separation

No CEO title currently disclosed. The company is run by an Executive Management Team led by the two director-shareholders. A "Chairman" is cited only by an aggregator [S7].

Governance code

No adoption of the Wates Principles disclosed in sources retrieved.

Identity verification

Both directors' Companies House identity verification is due by 30 October 2026 under ECCTA 2023 [S20]

Major Shareholders

HolderStakeBasis

Wellstopco Limited

≥75% shares and voting rights

PSC register, from 26 Mar 2026

Underlying owners of Wellstopco

Not disclosed in sources retrieved. The 2022 MBO named Birch, Law and Ogden as shareholders; CB Insights also lists Stuart Law, Carl Birch, Gary Ogden and Key Capital Partners (historic) as investors.

Press / aggregator

Key Capital Partners

Exited (realised) at the October 2022 secondary MBO

KCP website

LDC

Listed by PitchBook as an investor

—

Competitive Landscape

Competitors by Segment

Business lineCompetitorType / HQRelative positioning vs. Wells

Functional additive masterbatch (global)

Avient Corporation (incl. former Clariant Masterbatches)

NYSE-listed, USA

Global scale leader with a broad colour and additive portfolio; far larger

Functional additive masterbatch (global)

Ampacet Corporation

Private, USA

Large global masterbatch player, strong in film additives

Functional additive masterbatch

LyondellBasell (former A. Schulman masterbatch)

NYSE-listed, NL/USA

Integrated resin producer with masterbatch arm

Functional additive masterbatch

Tosaf

Private, Israel

Strong in additive masterbatch for film; European plants

Functional additive masterbatch

Kafrit Group

Listed in Tel Aviv, Israel

Additive masterbatch specialist (film additives)

Functional additive masterbatch

Gabriel-Chemie

Private, Austria

European colour and additive masterbatch

Functional additive masterbatch

Plastika Kritis

Athens-listed, Greece

Large European masterbatch producer, strong in agricultural film

UK masterbatch peers

Broadway Colours; Silvergate Plastics; Hubron International

Private, UK

Mostly colour- or black-masterbatch focused, so limited overlap with Wells' additive niche

Biodegradable additives (vs Reverte™)

Symphony Environmental Technologies (d2w)

AIM-listed, UK

Direct oxo-biodegradable competitor; similar scale; the only listed pure-play comparator

Biodegradable additives (vs Reverte™)

EPI Environmental Products (TDPA)

Private, Canada

Oxo-biodegradable competitor

Antimicrobial additives (vs BACTIglas™)

Addmaster (Biomaster); BioCote; Microban International; Sanitized AG

Private (UK, UK, USA, Switzerland)

Antimicrobial brand/licensing specialists; several license technology rather than compound

Peer Comparison FY2013

MetricWells PM (FY to Jun-2025)Symphony Environmental (FY Dec-2025)

Revenue

—

£5.73m (2024: £6.59m) [S73]

Revenue growth

—

−13% [S73]

Gross margin

—

51% (2024: 46%) [S73]

Net result

—

Loss of £2.50m [S75]

Employees

~60 [S24]

28 [S75]

Listing

Private

AIM (SYM); market cap about £19.5m (Jul 2026) [S75]

Company Snapshot

60

Employees

1984

Founded

Staffordshire, United Kingdom

Headquarters

SWOT Analysis

Strengths

  • Leading UK independent position in specialist additive masterbatch: Self-described largest independent UK specialist; capacity above 12,000 t/a [S4]
  • Two proprietary brands with 20+ years of history: BACTIglas™ since 1999; Reverte™ since 2003/2005 [S59]
  • Repeated capacity investment: +25% output (2013); +40% facility (2018, two twin-screw lines); Innovation Centre and warehouse (2022) [S3][S2][S59]
  • Historically high profitability: FY2010 PBT of £1.4m on £8.7m sales (16% margin) [S8]
  • Strong ESG credentials relative to size: ISO 14001 (2019); EcoVadis Silver (2020) then Gold (2022); BPF pellet-loss recognition (Jun 2025) [S59][S60]
  • Aligned, experienced management ownership: Birch (director since 2005) and Law (secretary since 2009, director since 2011) led the 2022 MBO; technical head is a shareholder [S20][S52]
  • Regulatory-affairs depth: Dedicated MRSC regulatory manager; PFAS and microplastics statements (2025–26) [S60]

Weaknesses

  • Small scale versus global rivals: About 60 employees [S24]
  • Single-location asset base: All four sites are in Stone, Staffordshire [S4]
  • Thin statutory governance: Two executive directors; no independent non-executives on the register [S20]
  • Low disclosure / visibility: Aggregators conflict sharply on headcount (25 vs 57–60) and revenue [S7][S62][S63]
  • Recurring late accounts filing (apparent): FY2022, FY2023 and FY2025 accounts filed 8–14 days after the nine-month deadline [S19]
  • Brand concentration risk in a contested technology: Reverte™ was the central 2011 investment thesis [S54], and its technology class faces EU restrictions

Opportunities

  • Recyclate-enabling additives: Desiccant and odour products positioned for recycled feedstocks [S1]
  • PFAS substitution: PFAS-free process aids; April 2026 PPWR clarification [S60]
  • European expansion: Plastteknik Nordic, AMI Málaga and Plastics Live Ireland participation (2025–26); WMG project targets UK and European share growth [S60][S24]
  • Biopolymer growth: Compol™ range; experience with bio-based and compostable carriers [S4][S59]
  • Regulatory acceptance of biodegradable additives outside the EU: Peer evidence: Jalisco, Mexico legislation permitting d2w-type technology [S71]
  • Grant-funded digitalisation: Made Smarter grant of £16k+ for testing equipment (2026) [S24]
  • Refinanced balance sheet: September 2026 refinancing activity could fund capex [S19] (terms unknown)

Threats

  • EU restrictions and microplastics scrutiny of oxo-type additives: Wells felt the need to issue a microplastics statement (Nov 2025) and test report (Jun 2026) [S60]
  • Volatile demand for biodegradable additives: Peer Symphony's revenue fell 13% in 2025 [S73]
  • Consolidation of large competitors: Clariant Masterbatches absorbed by Avient; A. Schulman by LyondellBasell (industry structure)
  • Raw-material and energy cost inflation in the UK: Common to UK compounders; no company-specific figure retrieved
  • Tighter biocide regulation for antimicrobials: BACTIglas™ depends on approved active substances (regulatory-intensive niche)
  • Customer concentration: Unknown. The 2013 growth was tied to blue-chip contract wins [S3], which implies key-account dependence.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
27 Mar 2025Easter production shutdown notice [S60]Routine operations
17 Mar 2025FY2024 full accounts (YE 30 Jun 2024, 37 pp) filed [S19]Statutory
18 Mar 2025Launch of revertebio.com [S60]Brand reinvestment in Reverte™
1 Apr 2025Announces first exhibition at Plastteknik Nordic (7–8 May 2025) [S60]Nordic market entry push
7–8 May 2025Exhibits at Plastteknik Nordic [S60]European expansion
31 May 2025Satisfaction of charge 12 and charge 018226120013 in full [S19]Legacy security released (deleveraging signal)
9 Jun 2025Announces exhibition at AMI Masterbatch, Málaga (17–18 Jun 2025) [S60]Positioning within the masterbatch community
17–18 Jun 2025AMI Masterbatch conference attendance [S60]Industry visibility
27 Jun 2025BPF article: Wells sets an industry standard in pellet-loss prevention (Operation Clean Sweep) [S60]ESG credential; relevant to the forthcoming EU pellet-loss regulation
16 Oct 2025Confirmation statement (no updates) [S19]Statutory
17 Oct 2025EU PFAS regulatory update published [S60]Customer guidance; product transition
29 Oct 2025Announces Plastics Live Ireland 2025 [S60]Irish market development
18 Nov 2025Microplastics regulatory statement issued [S60]Defence of product legitimacy amid microplastic regulation
21 Nov 2025Seasonal closure notice [S60]Routine
11 Mar 2026Announces AMI Stretch & Shrink Film, Málaga 2026 [S60]Film-additive marketing
26 Mar 2026Wellstopco Limited becomes PSC; R&E Holdings ceases (filed 23 Jul 2026) [S61][S19]Ownership-structure change
14 Apr 2026FY2025 full accounts (YE 30 Jun 2025, 35 pp) filed [S19]Statutory; latest audited data
24 Apr 2026PFAS-free process aids regulation clarification (PPWR) [S60]Product compliance; commercial positioning
12 May 2026Announces Interplas 2026 (NEC, 2–4 Jun) [S60]Domestic marketing
2–4 Jun 2026Exhibits at Interplas 2026; reports a successful show (8 Jun) [S60]Commercial momentum
19 Jun 2026Reverte™ microplastic report published [S60]Scientific defence of the core brand
29 Jun 2026WMG / Made Smarter case study: Instron investment, £16k+ grant, nearly 60 staff, UK and Europe growth ambition [S24]Capability investment; headcount data point
23 Jul 2026PSC filings (PSC02 / PSC07) lodged [S19]Registry
3 Sep 2026Charge 018226120018 created (registered 8 Sep) [S19]New secured financing
10 Sep 2026Charges 018226120015 and 018226120016 satisfied in full; announces AMI Compounding & Recycling Expo (23–24 Sep) [S19][S60]Release of MBO-era security; marketing
14 Sep 2026Charge 018226120018 recorded as satisfied in full [S19]Unusual short-lived charge; requires clarification
16 Sep 2026Confirmation statement made "with updates" [S19]Likely reflects shareholding/PSC changes
23–24 Sep 2026AMI Compounding & Recycling Expo [S60]Recycling-market positioning

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Income Statement

1 chart
Income Statement: Revenue rose from GBP 8.7 Mn in FY2010 to GBP 10 Mn in FY2013.
WELLS PERFORMANCE MATERIALS LIMITED — Income Statement
Series (GBP Mn)FY2010FY2013
Revenue8.710
Pre-tax profit1.4—

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. S1Interplas Insights, "Improving sustainability with additive masterbatch" (Aug 2023) – interplasinsights.com
  2. S2Knowde supplier profile (company self-description incl. May 2018 expansion) – knowde.com
  3. S3British Plastics & Rubber, "Oxo-biodegradable and degradable additives drive investment at Wells Plastics" (c. Jan 2013) – britishplastics.co.uk
  4. S4British Plastics Federation member directory, Wells Performance Materials Ltd – bpf.co.uk
  5. S6CB Insights, Wells Plastics profile – cbinsights.com
  6. S7a-leads company profile (aggregator) – a-leads.co
  7. S8TheBusinessDesk (North West), "KCP funds MBO of Wells Plastics" (Feb 2011)
  8. S9Prospeo company profile (aggregator)
  9. S10Companies House, company overview 01822612
  10. S19Companies House, filing history 01822612 (retrieved 8 Oct 2026)
  11. S20Companies House, officers 01822612 (retrieved 8 Oct 2026)
  12. S23Interplas Insights, "Wells celebrates 40 years and rebrands with new name" (Jun 2024)
  13. S24WMG, University of Warwick, "Unlocking growth, new markets and a £16k+ grant: Wells Performance Materials' journey with WMG" (29 Jun 2026)
  14. S39ltds.uk registry mirror, 01822612
  15. S50CB Insights, Wells Plastics financials/funding page
  16. S51Plastics Today, "Wells Plastics undergoes equity-backed management buyout" (18 Feb 2011)
  17. S52Interplas Insights, "Wells Plastics announces management buyout" (Oct 2022)
  18. S53Crowe UK, "Management Buy Out: Wells Plastics Limited" (9 Nov 2022)
  19. S54TheBusinessDesk (Yorkshire), "KCP backs Wells Plastics MBO" (Feb 2011)
  20. S57Key Capital Partners, portfolio page – Wells Plastics (realised)
  21. S59Wells Performance Materials website, homepage, timeline and product menu – wellspm.com
  22. S60Wells Performance Materials, News page (retrieved 8 Oct 2026)
  23. S61Companies House, persons with significant control 01822612
  24. S62PitchBook, Wells Plastics profile (preview)
  25. S63Datanyze, Wells Plastics profile (aggregator; contains address error)
  26. S69TheBusinessDesk (Yorkshire), KCP/Wells MBO article (board detail)
  27. S70Owler, Wells (wellspm) news index
  28. S71Symphony Environmental Technologies plc, Interim Results H1-2025 (30 Sep 2025)
  29. S72Symphony Environmental, Preliminary Results FY2025 (via Proactive Investors, Jun 2026)
  30. S73Sharecast via Hargreaves Lansdown, "Revenue falls, margins improve for Symphony Environmental Tech" (23 Jun 2026)
  31. S74Symphony Environmental, AGM Statement (4 Aug 2026)
  32. S75StockAnalysis, Symphony Environmental Technologies (AIM: SYM) quote page (Jul 2026)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.